rs10812615
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018325.5(C9orf72):c.600+146A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.42 in 365,862 control chromosomes in the GnomAD database, including 33,262 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 13014 hom., cov: 33)
Exomes 𝑓: 0.43 ( 20248 hom. )
Consequence
C9orf72
NM_018325.5 intron
NM_018325.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.320
Publications
4 publications found
Genes affected
C9orf72 (HGNC:28337): (C9orf72-SMCR8 complex subunit) The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]
C9orf72 Gene-Disease associations (from GenCC):
- frontotemporal dementia and/or amyotrophic lateral sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- progressive myoclonus epilepsyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| C9orf72 | NM_018325.5 | c.600+146A>G | intron_variant | Intron 4 of 10 | ENST00000380003.8 | NP_060795.1 | ||
| C9orf72 | NM_001256054.3 | c.600+146A>G | intron_variant | Intron 4 of 10 | NP_001242983.1 | |||
| C9orf72 | NM_145005.7 | c.600+146A>G | intron_variant | Intron 4 of 4 | NP_659442.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| C9orf72 | ENST00000380003.8 | c.600+146A>G | intron_variant | Intron 4 of 10 | 1 | NM_018325.5 | ENSP00000369339.3 |
Frequencies
GnomAD3 genomes AF: 0.407 AC: 61821AN: 151908Hom.: 13000 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
61821
AN:
151908
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.430 AC: 91893AN: 213836Hom.: 20248 AF XY: 0.433 AC XY: 47663AN XY: 109952 show subpopulations
GnomAD4 exome
AF:
AC:
91893
AN:
213836
Hom.:
AF XY:
AC XY:
47663
AN XY:
109952
show subpopulations
African (AFR)
AF:
AC:
1878
AN:
6286
American (AMR)
AF:
AC:
2769
AN:
6588
Ashkenazi Jewish (ASJ)
AF:
AC:
3203
AN:
7818
East Asian (EAS)
AF:
AC:
6417
AN:
19318
South Asian (SAS)
AF:
AC:
1201
AN:
2392
European-Finnish (FIN)
AF:
AC:
8283
AN:
17224
Middle Eastern (MID)
AF:
AC:
419
AN:
1134
European-Non Finnish (NFE)
AF:
AC:
62008
AN:
139192
Other (OTH)
AF:
AC:
5715
AN:
13884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2369
4738
7108
9477
11846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.407 AC: 61868AN: 152026Hom.: 13014 Cov.: 33 AF XY: 0.408 AC XY: 30296AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
61868
AN:
152026
Hom.:
Cov.:
33
AF XY:
AC XY:
30296
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
12338
AN:
41474
American (AMR)
AF:
AC:
6389
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1387
AN:
3466
East Asian (EAS)
AF:
AC:
2161
AN:
5176
South Asian (SAS)
AF:
AC:
2365
AN:
4832
European-Finnish (FIN)
AF:
AC:
5082
AN:
10526
Middle Eastern (MID)
AF:
AC:
110
AN:
290
European-Non Finnish (NFE)
AF:
AC:
30836
AN:
67958
Other (OTH)
AF:
AC:
839
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1889
3779
5668
7558
9447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1682
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.